Edgewise Therapeutics (EWTX.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec24

Analyst Maintains Hold Rating on Edgewise Therapeutics

15:17

Edgewise Therapeutics announces positive interim safety results for drug EDG-7500 trial

13:00

Nov18

Evercore ISI Analyst Maintains Buy Rating on Edgewise Therapeutics

10:42

Nov14

JP Morgan Raises Target Price, Driving Edgewise Therapeutics Stock Up

17:29

Nov13

Piper Sandler Analyst Maintains Buy Rating for Edgewise Therapeutics

11:52

Nov7

H.C. Wainwright Reiterates Buy Rating on Edgewise Therapeutics

12:02

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -40.67 M, EPS -0.3854

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -36.12 M, EPS -0.3441

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -40.8 M, EPS -0.4288

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More